No financial scores yet. The Financial Health Scanner runs nightly and will score this company on its next cycle.
Recent Signals
20 foundBioNTech SE
is_buy: false · shares: 27000 · filing_date: 2026-10-09
10/9/2026
50%
BioNTech SE
is_buy: false · shares: 36209 · filing_date: 2026-10-09
10/9/2026
50%
BioNTech SE
is_buy: false · shares: 24000 · filing_date: 2026-10-07
10/7/2026
50%
BioNTech SE
is_buy: false · shares: 21000 · filing_date: 2026-10-06
10/6/2026
50%
BioNTech SE
is_buy: false · shares: 72000 · filing_date: 2026-10-06
10/6/2026
50%
BioNTech SE
is_buy: false · shares: 17000 · filing_date: 2026-10-02
10/2/2026
50%
BioNTech SE
is_buy: false · shares: 17000 · filing_date: 2026-10-02
10/2/2026
50%
BioNTech SE
is_buy: false · shares: 27000 · filing_date: 2026-09-28
9/28/2026
50%
BioNTech SE
is_buy: false · shares: 34000 · filing_date: 2026-09-28
9/28/2026
50%
BioNTech SE
is_buy: false · shares: 39000 · filing_date: 2026-09-24
9/24/2026
50%
BioNTech SE
is_buy: false · shares: 30000 · filing_date: 2026-09-24
9/24/2026
50%
BioNTech SE
is_buy: false · shares: 46000 · filing_date: 2026-09-22
9/22/2026
50%
BioNTech SE
is_buy: false · shares: 33000 · filing_date: 2026-09-22
9/22/2026
50%
BioNTech SE
is_buy: false · shares: 30000 · filing_date: 2026-09-18
9/18/2026
50%
BioNTech SE
news_score: null · bearish_pct: null · bullish_pct: null
5/5/2026
55%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
Watch Reason
S&P 500 / major index component — seeded via EDGAR